These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8091356)

  • 1. [Calcium antagonists and the central nervous system].
    Allain H; Bentué-Ferrer D; Saiag B; Belliard S; Thaminy S
    Therapie; 1993; 48 Spec No():697-705. PubMed ID: 8091356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
    Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
    Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ; ter Laak MP; Kamal A; Gispen WH
    Brain Res; 2005 Feb; 1035(1):86-93. PubMed ID: 15713280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
    Eigenmann R; Gerold M; Hefti F; Jovanovic D; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1401-10. PubMed ID: 7197946
    [No Abstract]   [Full Text] [Related]  

  • 5. Redundancy of Cav2.1 channel accessory subunits in transmitter release at the mouse neuromuscular junction.
    Kaja S; Todorov B; van de Ven RC; Ferrari MD; Frants RR; van den Maagdenberg AM; Plomp JJ
    Brain Res; 2007 Apr; 1143():92-101. PubMed ID: 17320843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the subchronic administration of calcium-channel blockers on CNS excitability].
    Kozlovskiĭ VL; Mosin AE; Ivakina LV
    Eksp Klin Farmakol; 1996; 59(1):14-6. PubMed ID: 8704622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K
    Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-type calcium channels reduce ROS generation in cerebellar granule cells following kainate exposure.
    Leski ML; Hassinger LC; Valentine SL; Baer JD; Coyle JT
    Synapse; 2002 Jan; 43(1):30-41. PubMed ID: 11746731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological actions of aminopyridines and related compounds.
    Bowman WC; Savage AO
    Rev Pure Appl Pharmacol Sci; 1981; 2(4):317-71. PubMed ID: 6278543
    [No Abstract]   [Full Text] [Related]  

  • 10. Static magnetic field expose enhances neurotransmission in crayfish nervous system.
    Yeh SR; Yang JW; Lee YT; Tsai LY
    Int J Radiat Biol; 2008 Jul; 84(7):561-7. PubMed ID: 18661372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of anesthetics on neurotransmission in the central nervous system. Review].
    Rodríguez Vila D; Martí Viaño JL
    Rev Esp Anestesiol Reanim; 1978 Jul; 25(4):317-28. PubMed ID: 211564
    [No Abstract]   [Full Text] [Related]  

  • 12. Presynaptic calcium channels: structure, regulators, and blockers.
    Kisilevsky AE; Zamponi GW
    Handb Exp Pharmacol; 2008; (184):45-75. PubMed ID: 18064411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of L-type voltage-gated calcium channel-dependent synaptic plasticity by ethanol: analysis of miniature synaptic currents and dendritic calcium transients.
    Hendricson AW; Thomas MP; Lippmann MJ; Morrisett RA
    J Pharmacol Exp Ther; 2003 Nov; 307(2):550-8. PubMed ID: 12970385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists and ischemic heart disease].
    Simon K; Vályi P; Szépvölgyi A; Badics A; Böhm T
    Orv Hetil; 1996 Sep; 137(39):2131-6. PubMed ID: 8927361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation.
    Parri HR; Gould TM; Crunelli V
    Nat Neurosci; 2001 Aug; 4(8):803-12. PubMed ID: 11477426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some pharmacological properties of pyrogallol].
    Lastowski Z
    Ann Univ Mariae Curie Sklodowska Med; 1968; 23():115-20. PubMed ID: 5745728
    [No Abstract]   [Full Text] [Related]  

  • 18. General pharmacological profile and effects of E-4716, a novel histamine receptor blocker, on the central nervous system.
    Fisas MA; Gutiérrez B; Fort M; Dordal A; García C; Farré AJ
    Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):199-210. PubMed ID: 9646282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system.
    Pickering M; Cumiskey D; O'Connor JJ
    Exp Physiol; 2005 Sep; 90(5):663-70. PubMed ID: 15944202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.